ProShares UltraShort Nasdaq Biotech (BIS) Rises 6.35% for Dec 8

Dec 8 is a positive day so far for ProShares UltraShort Nasdaq Biotech (NASDAQ:BIS) as the ETF is active during the day after gaining 6.35% to hit $20.6 per share. The exchange traded fund has 26.84 million net assets and 3.36% volatility this month.

Over the course of the day 47,417 shares traded hands, as compared to an average volume of 78,800 over the last 30 days for ProShares UltraShort Nasdaq Biotech (NASDAQ:BIS).

The ETF is -31.09% of its 52-Week High and 16.67% of its low, and is currently having ATR of 0.83. This year’s performance is -7.30% while this quarter’s performance is -3.95%.

The ETF’s YTD performance is -15.01%, the 1 year is -17.69% and the 3 year is -14.57%.

The fund’s top holdings are: Nasdaq Biotechnology Index Swap Societe Generale for 118.86% of assets, Nasdaq Biotechnology Index Swap Bank Of America Na for 33.80%, Ishares Biotech (Ibb) Swap Bank Of America Na for 31.08%, United States Treasury Bills for 6.91%, Nasdaq Biotechnology Index Swap Ubs Ag for 1.47%, Nasdaq Biotechnology Index Swap Morgan Stanley & Co. International Plc for 0.48%, Nasdaq Biotechnology Index Swap Credit Suisse International for 0.43%, Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc for 0.21%, Nasdaq Biotechnology Index Swap Citibank Na for 0.11%. The ETF sector weights are: Basic Materials 0.00%, CONSUMER_CYCLICAL 0.00%, Financial Services 0.00%, Realestate 0.00%, Consumer Defensive 0.00%, Healthcare 0.00%, Utilities 0.00%, Communication Services 0.00%, Energy 0.00%, Industrials 0.00%, Technology 0.00%. The ETF currently as yield.

More notable recent ProShares UltraShort Nasdaq Biotech (NASDAQ:BIS) news were published by: Nasdaq.com which released: “Internet giants pose existential threat to banks – BIS chief – Nasdaq” on December 04, 2018, also Nasdaq.com with their article: “Ahold Delhaize announces pricing of cash tender offer for up to $350 million principal amount of its 5.70% senior notes due 2040 – Nasdaq” published on December 04, 2018, Nasdaq.com published: “RTI Surgical Gains From HealthPartners’ Nod for SI Surgery – Nasdaq” on November 23, 2018. More interesting news about ProShares UltraShort Nasdaq Biotech (NASDAQ:BIS) were released by: Nasdaq.com and their article: “Ahold Delhaize announces early results of cash tender offer for up to $350 million principal amount of its 5.70% senior notes due 2040 – Nasdaq” published on December 04, 2018 as well as Nasdaq.com‘s news article titled: “Banco Santander Chile issues second floating bond in Chilean pesos in the local market – Nasdaq” with publication date: November 29, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.